Impact of Low-Dose Alendronate Therapy on Target Joints in Hemophilia Patients in a Low-Income Country
نویسندگان
1 Lorestan University of Medical Sciences, Khorramabad, Iran
2 Lorestan University of Medical Sciences, Khorramabad, Iran
3 Lorestan University of Medical Sciences, Khorramabad, Iran
4 Iranian Comprehensive Hemophilia Care Center, Tehran, Iran
5 Health service management, Science and Research branch, Islamic Azad University,Tehran, Iran
doi
10.61186/ijbc.16.2.102چکیده
Background: Osteoporosis poses a significant clinical challenge for patients with hemophilia (PWH), primarily due to repeated intra-articular bleeding and joint inflammation. The objective of this study was to assess the impact of a combination of calcium-vitamin D and alendronate tablets on reducing the frequency of hemarthrosis in PWH in Lorestan province. Methods: This ...